The genetic engineering of organ-donor animals to decrease the risk of human immune system rejection poses ethical and psychological challenges to the long-held boundary between humans and other animal species.
The implementation of breakthrough quality improvement initiatives has been successful in closing the gap between the number of organs that are available and the number of patients who need them.
Physicians can ethically withhold information in situations where full disclosure of a diagnosis or treatment would cause great psychological harm to the patient.